IFA Talk is our flagship podcast, that fits perfectly into your busy life, bringing the latest insight, analysis, news and interviews to you, wherever you are.
IFA Talk Podcast – listen to the latest episode
Trending Articles
-
Mortgage choice dips as lenders tread cautiously | M&PI 20 | September 2025
Mortgage & Property Investment Magazine
Autumn brings change – and new opportunities As we see out the end of summer 2025, in steps autumn, a season of change a…
-
Government’s renters’ rights bill rejection exposes fundamental misreading of rental market
Following the Commons debate last night, which saw the rejection of nearly all non-Government amendments to the Renters’…
-
Pure Retirement commit to driving industry best outcomes with new resources
Lifetime mortgage lender Pure Retirement has underlined its commitment to supporting advisers in delivering best outcome…
-
No-fault evictions: what advisers need to know | Guest insight from Cordelia Smith, Hunters Law LLP
Exclusives, Mortgage and Property
As the Renters’ Rights Bill edges closer to implementation, mortgage advisers should be aware of its ripple effects acro…
-
What Hargreaves Lansdown wants for savers and investors in the Budget
With the Budget set for 26 November, Hargreaves Lansdown highlights what savers and investors should watch for: protecti…
-
UK GDP stalls in July raising questions for advisers ahead of Autumn Budget | Industry experts share their analysis
Data released from the ONS today has indicated that monthly GDP growth ground to a halt, after a promising 0.4% rise in…
-
PEXA hits remortgage milestone as it processes over £200M in UK transactions
PEXA, the digital property exchange platform, today announces that it has processed over £200M in UK remortgage transact…
-
What landlords need to know as rent increases come under review
The Renters’ Rights Bill will limit rent increases to a single legal process. Allison Thompson explains what this means…
-
Viewpoint | Artemis’ Liam O’Donnell on why gilts might defy the UK’s doom-and-gloom outlook
The headlines don’t tell the whole story: UK gilts are undermining the prevailing doom-and-gloom view. Here, Liam O’Donn…
-
ECB maintains key interest rates – industry experts share their reactions
Earlier today, news broke that the European Central Bank (ECB) has decided to maintain the current interest rates. Infla…
Exclusives
Latest Publications
Explore our latest reports, magazines and special supplements
More Latest News
-
Grainger appoints John Blanshard as director of operations
Residential landlord Grainger has appointed John Blanshard as its director of operations. Blanshard – who was previously chief customer officer at Unite…
-
Kingfisher reinstates dividend as profits soar on lockdown DIY boom
B&Q owner Kingfisher reinstated its dividend as it reported soaring annual profits and a strong start to the new fiscal year on…
-
Europe open: Stocks lower on Turkish lira crisis, summer holiday fears
European shares opened the week in downbeat mood as the plunging Turkish lira and weak travel stocks hit markets. The pan-European STOXX…
-
ESG – an easy guide and CPD to make sure you are on top of this fast-growing investment trend
Understanding ESG. Complete the training and qualify for structured CPD. Click HERE
-
Futura Medical gets FDA OK for confirmatory study of erectile dysfunction gel
Futura Medical shares surged on Monday after the company said it had agreed with the US Food and Drug Administration on the…
-
Saudi Aramco pays $75m dividend despite profits slump
Oil giant Saudi Aramco paid out $75bn in dividends as it reported a sharp fall in annual profits on the back of…
-
Unite gets planning permission for Nottingham development
Student housing developer and operator Unite Group has received resolution to grant planning permission for its 700-bed student accommodation development at Derby…
-
AstraZeneca vaccine gets positive US trial results
A final-stage US trial of AstraZeneca’s Covid-19 vaccine has found it to be 100% effective at keeping patients out of hospital. The…
-
US trial finds AstraZeneca Covid-19 vaccine 79% effective, no safety issues
AstraZeneca said on Monday that a US trial of the coronavirus vaccine it has developed with the University of Oxford showed it…
-
London pre-open: Stocks seen lower amid rise in Europe Covid cases
London stocks were set to fall at the open on Monday amid concerns about the slow vaccine rollout in Europe and rising…